Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides - PubMed (original) (raw)
. 2005 Aug 29;489(3):275-92.
doi: 10.1002/cne.20598.
Affiliations
- PMID: 16025454
- DOI: 10.1002/cne.20598
Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides
Ghazal Banisadr et al. J Comp Neurol. 2005.
Abstract
The monocyte chemoattractant protein-1 (MCP-1/CCL2) and its receptor CCR2 are key modulators of immune functions. In the nervous system, MCP-1/CCL2 is implicated in neuroinflammatory pathologies. However, cerebral functions of MCP-1/CCL2 under normal conditions are still unclear. In this study, using reverse transcriptase-polymerase chain reaction (RT-PCR) and specific rat MCP-1 enzyme-linked immunosorbent assay (ELISA) approaches, we observed that MCP-1/CCL2 mRNA and protein were expressed in different punched regions of the normal rat central nervous system. Immunohistochemical studies further revealed that this chemokine is constitutively expressed not only in astrocytes but also in neurons, in discrete neuroanatomical regions. Neuronal expression of MCP-1/CCL2 is mainly found in the cerebral cortex, globus pallidus, hippocampus, paraventricular and supraoptic hypothalamic nuclei, lateral hypothalamus, substantia nigra, facial nuclei, motor and spinal trigeminal nuclei, and gigantocellular reticular nucleus and in Purkinje cells in the cerebellum. Moreover, we obtained the first evidence that MCP-1/CCL2 is constitutively expressed in cholinergic neurons, notably in the magnocellular preoptic and oculomotor nuclei, and in dopaminergic neurons of the substantia nigra pars compacta. In addition, in the lateral hypothalamic area, MCP-1/CCL2 co-localized with melanin-concentrating hormone-expressing neurons. Interestingly, we demonstrate a co-localization of MCP-1/CCL2 with vasopressin in magnocellular neuronal cell bodies and processes in the supraoptic and paraventricular hypothalamic nuclei, as well as in processes in the internal layer of the median eminence and in the posterior pituitary. Taken together, our data suggest that MCP-1/CCL2 could act as a modulator of neuronal activity and neuroendocrine functions.
(c) 2005 Wiley-Liss, Inc.
Similar articles
- Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones.
Gosselin RD, Varela C, Banisadr G, Mechighel P, Rostene W, Kitabgi P, Melik-Parsadaniantz S. Gosselin RD, et al. J Neurochem. 2005 Nov;95(4):1023-34. doi: 10.1111/j.1471-4159.2005.03431.x. Epub 2005 Sep 7. J Neurochem. 2005. PMID: 16150057 - Expression of latent transforming growth factor beta binding proteins in the rat brain.
Dobolyi A, Palkovits M. Dobolyi A, et al. J Comp Neurol. 2008 Mar 20;507(3):1393-408. doi: 10.1002/cne.21621. J Comp Neurol. 2008. PMID: 18196529 - Chemokines and neuromodulation.
Mélik-Parsadaniantz S, Rostène W. Mélik-Parsadaniantz S, et al. J Neuroimmunol. 2008 Jul 31;198(1-2):62-8. doi: 10.1016/j.jneuroim.2008.04.022. Epub 2008 Jun 9. J Neuroimmunol. 2008. PMID: 18538863 Review. - Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
Daly C, Rollins BJ. Daly C, et al. Microcirculation. 2003 Jun;10(3-4):247-57. doi: 10.1038/sj.mn.7800190. Microcirculation. 2003. PMID: 12851642 Review.
Cited by
- Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF.
Breese GR, Knapp DJ. Breese GR, et al. Alcohol. 2016 May;52:9-23. doi: 10.1016/j.alcohol.2016.01.005. Epub 2016 Feb 24. Alcohol. 2016. PMID: 27139233 Free PMC article. Review. - Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C-C motif) ligand 2 levels in rats.
Loftis JM, Navis T, Taylor J, Hudson R, Person U, Lattal KM, Vandenbark AA, Shirley R, Huckans M. Loftis JM, et al. Eur J Pharmacol. 2020 Aug 5;880:173175. doi: 10.1016/j.ejphar.2020.173175. Epub 2020 May 13. Eur J Pharmacol. 2020. PMID: 32416183 Free PMC article. - Immune treatments for alcohol use disorder: A translational framework.
Meredith LR, Burnette EM, Grodin EN, Irwin MR, Ray LA. Meredith LR, et al. Brain Behav Immun. 2021 Oct;97:349-364. doi: 10.1016/j.bbi.2021.07.023. Epub 2021 Jul 31. Brain Behav Immun. 2021. PMID: 34343618 Free PMC article. Review. - Chemokines, cytokines and substance use disorders.
Ahearn OC, Watson MN, Rawls SM. Ahearn OC, et al. Drug Alcohol Depend. 2021 Mar 1;220:108511. doi: 10.1016/j.drugalcdep.2021.108511. Epub 2021 Jan 8. Drug Alcohol Depend. 2021. PMID: 33465606 Free PMC article. Review. - TLR7-mediated skin inflammation remotely triggers chemokine expression and leukocyte accumulation in the brain.
McColl A, Thomson CA, Nerurkar L, Graham GJ, Cavanagh J. McColl A, et al. J Neuroinflammation. 2016 May 9;13(1):102. doi: 10.1186/s12974-016-0562-2. J Neuroinflammation. 2016. PMID: 27160148 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous